Home Ariad receives nod to resume US sales of leukemia drug
 

Keywords :   


Ariad receives nod to resume US sales of leukemia drug

2013-12-21 12:09:24| Biotech - Topix.net

Seven weeks after Ariad Pharmaceuticals Inc. was forced to halt US sales of its leukemia drug, prompting an outcry from patients and doctors, the Food and Drug Administration issued new safety measures Friday that will allow the Cambridge biotech to resume selling the medicine.

Tags: sales drug resume receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
More »